U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
151891151891Estrogen Deficiency and Cardiovascular Disease in Premenopausal WomenRecruitingNo Results AvailableEstrogen DeficiencyProcedure: Blood test|Genetic: Blood test|Procedure: Ultrasound of neck arteries|Procedure: Saliva testhttps://ClinicalTrials.gov/show/NCT00572858
151892151892Energy Costs of Spasticity in Spinal Cord Injury: A Pilot InvestigationRecruitingNo Results AvailableBasal Energy Expenditure|SpasticityOther: Weaning of Antispasticity Medicationhttps://ClinicalTrials.gov/show/NCT00572845
151893151893Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University SettingCompletedHas ResultsHuman Papillomavirus InfectionBiological: Quadrivalent human papillomavirus vaccine on-time administration|Biological: Quadrivalent human papillomavirus vaccine delayed administrationhttps://ClinicalTrials.gov/show/NCT00572832
151894151894Hysteroscopy After Pretreatment With Misoprostol and Estradiol TrialCompletedNo Results AvailableCervical RipeningDrug: Misoprostol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00572819
151895151895Initiation of Insulin Aspart in Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin asparthttps://ClinicalTrials.gov/show/NCT00572806
151896151896A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown RiskCompletedNo Results AvailablePreeclampsiahttps://ClinicalTrials.gov/show/NCT00572793
151897151897Can CT Enteroclysis Predict the Outcome of Crohn's DiseaseCompletedNo Results AvailableCrohn's Diseasehttps://ClinicalTrials.gov/show/NCT00572780
151898151898Evaluation of the Effect of Dextro-Amphetamin Added to Physiotherapy in Patients After StrokeTerminatedNo Results AvailableStrokeDrug: Dextro-Amphetamin|Other: Glucosehttps://ClinicalTrials.gov/show/NCT00572767
151899151899Phase II Trial to Evaluate the Safety and Efficacy of the Dry Circumcision MethodRecruitingNo Results AvailableCircumcision|MaleProcedure: Circumcisionhttps://ClinicalTrials.gov/show/NCT00572754
151900151900Treating Oxidative Stress and the Metabolic Pathology of AutismRecruitingNo Results AvailableAutistic DisorderDietary Supplement: B12|Dietary Supplement: Placebo|Dietary Supplement: folate|Dietary Supplement: B complex|Dietary Supplement: vitamin C|Dietary Supplement: cod liver oil|Dietary Supplement: Mineral complex|Dietary Supplement: carnitinehttps://ClinicalTrials.gov/show/NCT00572741
1519011519013'-Deoxy-3'-18F Fluorothymidine PET/CT in Predicting Response To Chemotherapy Before Surgery in Patients With Locally Advanced Breast CancerCompletedNo Results AvailableStage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast CancerDrug: Fluorothymidine F-18|Procedure: Positron Emission Tomography|Procedure: Computed Tomography|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00572728
151902151902Acute Kidney Injury in NeonatesWithdrawnNo Results AvailableAcute Kidney Injuryhttps://ClinicalTrials.gov/show/NCT00572715
151903151903Randomized,Multicentric Study to Treat Prolapse After Hysterectomy With Amreich Procedure or Total Prolift ProcedureRecruitingNo Results AvailablePelvic Organ ProlapseProcedure: Vaginal fixation Amreich-Richter|Procedure: Prolift totalhttps://ClinicalTrials.gov/show/NCT00572702
151904151904Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational DiabetesWithdrawnNo Results AvailableGestational DiabetesDrug: Exenatide|Genetic: Buccal/blood Sample Collectionhttps://ClinicalTrials.gov/show/NCT00572689
151905151905Optimalization of Nephroprotection Using N-AcetylcysteineCompletedNo Results AvailableChronic Kidney Disease|ProteinuriaDrug: ACC (N-acetylcysteine) 1200 mghttps://ClinicalTrials.gov/show/NCT00572663
151906151906Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired PatientsCompletedNo Results AvailableType 2 Diabetes MellitusDrug: vildagliptinhttps://ClinicalTrials.gov/show/NCT00572650
151907151907Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's LymphomasCompletedNo Results AvailableSolid Tumors|Lymphoma, Non-HodgkinDrug: CEP-18770https://ClinicalTrials.gov/show/NCT00572637
151908151908Effect of Abdominal Obesity on Heart Metabolism and FunctionRecruitingNo Results AvailableObesity|Diabetes Mellitus, Type 2Behavioral: Weight Loss Management Programhttps://ClinicalTrials.gov/show/NCT00572624
151909151909Human Mass Balance Study With BilastineCompletedNo Results AvailableHealthyDrug: [14C]-bilastinehttps://ClinicalTrials.gov/show/NCT00572611
151910151910Pilot Study of 18F Fluoropaclitaxel (FPAC)CompletedNo Results AvailableBreast CancerDrug: 4- [F-18] fluoropaclitaxelhttps://ClinicalTrials.gov/show/NCT00572598
151911151911Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative ColitisTerminatedNo Results AvailableUlcerative ColitisDrug: AEB071|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00572585
151912151912Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell TumorsCompletedNo Results AvailableGerm Cell TumorsDrug: Aprepitant|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00572572
151913151913Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus AureusCompletedNo Results AvailablePneumonia, Ventilator-AssociatedDrug: Vancomycin|Drug: Linezolidhttps://ClinicalTrials.gov/show/NCT00572559
151914151914Intelligent Control Approach to Anemia ManagementCompletedHas ResultsEnd-Stage Renal DiseaseOther: ESA Dose Adjustment per standard Anemia Management Protocol|Other: ESA Dose Adjustment per "Smart Anemia Manager" Algorithmhttps://ClinicalTrials.gov/show/NCT00572533
151915151915Effectiveness of Behavioral Treatments for Obesity and Major Depression in WomenCompletedNo Results AvailableDepression|ObesityBehavioral: Weight loss treatment|Behavioral: Behavior therapy for depression|Behavioral: Health education counselinghttps://ClinicalTrials.gov/show/NCT00572520
151916151916Multi-center Study to Evaluate the Safety and Efficacy of Aesculap MonoMax® for Abdominal Wall ClosureCompletedNo Results AvailablePrimary Median LaparotomyDevice: MonoMax®https://ClinicalTrials.gov/show/NCT00572507
151917151917AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia TreatmentCompletedNo Results AvailablePeripheral Artery DiseaseDevice: MAGIC EXPLORER (Biotronik AG)|Device: PLEON EXPLORER (Biotronik AG)https://ClinicalTrials.gov/show/NCT00572494
151918151918Axillary Reverse MappingRecruitingNo Results AvailableCancer of the BreastProcedure: Axillary Reverse Mappinghttps://ClinicalTrials.gov/show/NCT00572481
151919151919Statin Therapy Versus Placebo Prior to ProstatectomyActive, not recruitingNo Results AvailableCancer|ProstateDrug: Simvastatin|Other: Placebohttps://ClinicalTrials.gov/show/NCT00572468
151920151920Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.CompletedNo Results AvailablePrimary Open Angle Glaucoma|Ocular HypertensionDrug: PF-04217329 - Lowest Dose|Drug: PF-04217329 - Low Dose|Drug: PF-04217329 - Middle Dose|Drug: PF-04217329 - High Middle Dose|Drug: PF-04217329 - High Dose|Drug: PF-4217329 - Highest Dose|Drug: PF-04217329 - Vehicle|Drug: Latanoprost Vehicle|Drug: PF-04217329 - Low Dose|Drug: Latanoprost Vehicle|Drug: PF-04217329 - Middle Dose|Drug: Latanoprost Vehicle|Drug: PF-04217329 - High Dose|Drug: Latanoprost 0.005%|Drug: PF-04217329 - Low Dose|Drug: Latanoprost 0.005%|Drug: PF-04217329 - Middle Dose|Drug: Latanoprost 0.005%|Drug: PF-04217329 - High Dose|Drug: Latanoprost 0.005%|Drug: PF-04217329 - Vehiclehttps://ClinicalTrials.gov/show/NCT00572455

* Görseller ve İçerik tekif hakkına sahip olabilir